Media

Spruce Biosciences Reports First Quarter 2021 Financial Results And Provides Corporate Updates

Strongbridge Biopharma plc Reports First Quarter 2021 Financial Results and Provides Corporate Update

Fusion Pharmaceuticals Announces First Quarter 2021 Financial Results And Business Update

Aprea Therapeutics Reports First Quarter 2021 Financial Results and Provides Update on Business Operations

Fusion Pharmaceuticals Announces Clinical Collaboration With Merck To Evaluate Fusion’s Targeted Alpha Therapy (TAT) In Combination With Merck’s KEYTRUDA® (Pembrolizumab) In Patients With Solid Tumors Expressing IGF-1R

Strongbridge Biopharma plc to Host First Quarter 2021 Financial Results Conference Call on May 12, 2021

Oncopeptides completes patient enrollment in phase 2 PORT study

Interim report January – March 2021

The Norwegian Directorate of Health Chooses Doctrin For Its National Triage Solution